Founded in 1969, Pharmathen has grown to become one of the largest, vertically integrated developers of complex drug delivery technologies.
Pharmathen remains committed to its vision to improve people’s lives through innovation and access to affordable medicines.
With best-in-class research & development capabilities, Pharmathen is currently working on one of the most extensive and advanced pipelines in the industry consisting of more than 40 products, with a focus on long-acting injectables (LAI), sustained release and ophthalmic formulations produced in its US FDA and EU approved manufacturing facilities in Greece. Pharmathen’s highly diversified product portfolio of more than 90 commercialized products is sold to 250 customers and accessed by patients in more than 90 countries worldwide.
Pharmathen is constantly strengthening its portfolio with innovative technologies and Long-Acting Therapeutic Technologies (LATTs), due to the three fully certified technological platforms it has developed. As a result, Pharmathen can provide a wide range of therapies aimed at enhancing patient compliance for those previously receiving "conventional" treatment and create new Life Cycle Management (LCM) opportunities.
Pharmathen maintains a strong presence in all major markets and collaborates with the most significant organizations in the global pharmaceutical market, with a broad partner network in more than 90 countries worldwide. The company ranks among the top 50 pharmaceutical research companies in Europe and is one of the largest private sector investors in research and development in Greece, with steady investments of €35 million annually in the R&D sector.
Pharmathen proudly employs more than 1.700 people from over 27 different nationalities, with 53% of its total workforce being female and 73% of Pharmathen's Research Operations Team also being women. The company's enduring success is attributed to the passion for creativity, the ethics, and dedication of its people, who share the same values and remain committed to the company's vision of making a difference in people’s lives.
pharma
then's
Vision
Pharmathen envisions driving innovation and excellence in the pharmaceutical industry, playing a pivotal role in advancing global health through research, development, and manufacturing of high-quality, effective, and accessible medicines. With a strong commitment to innovation, the company strives to address unmet medical needs and improve patient outcomes worldwide. Pharmathen fosters a culture of collaboration, bringing together scientific expertise, state-of-the-art technologies, and a passion for healthcare to make a tangible difference in people's lives.
Equally, Pharmathen recognizes the critical importance of education, particularly at the MSc level, as it lays the foundation for the next generation of pharmaceutical leaders, researchers, and innovators. By actively engaging with academic institutions and supporting advanced educational programs, Pharmathen ensures that students gain not only theoretical knowledge but also practical skills and industry insights. This alignment between academic learning and real-world applications equips students to tackle complex challenges in pharmaceutical science, empowering them to contribute meaningfully to the development of innovative therapies and advancements in global healthcare.
Through this dual focus on innovation and education, Pharmathen is shaping a healthier future while inspiring the leaders of tomorrow.